FDA MedWatch - TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules

If your email program has trouble displaying this email, view it as a web page
 
U.S. Food and Drug Administration Header

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

A new MedWatch Safety Alert:TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules intended for: Patient, Pharmacy, Health Professional was just added to the FDA MedWatch Webpage.
 
You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm609064.htm
 
 

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists

Comments

Popular Posts

January 3nd Nоte (Оpen Up)

Reduced Payment!.

We have Your e-Wallet ready. Claim in 3hrs

Your order requires immediate confirmation.

Beneficiary countersignature modification

You’re four weeks away from more followers 📱

The State Department requires proof that you are the owner.

Commissions Successfully

Fwd: Claim "Climate law & governance" for your profile